BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28622999)

  • 41. Editorial overview: Viral immunology: Dealing with bad news.
    Yewdell JW; Rimmelzwaan GF
    Curr Opin Virol; 2017 Feb; 22():viii-x. PubMed ID: 28279326
    [No Abstract]   [Full Text] [Related]  

  • 42. Vaccinating the inflammatory bowel disease patient.
    Desalermos AP; Farraye FA; Wasan SK
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):91-102. PubMed ID: 25160668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A proposed workflow for proactive virus surveillance and prediction of variants for vaccine design.
    Baker JJ; Mathy CJP; Schaletzky J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009624. PubMed ID: 34914686
    [No Abstract]   [Full Text] [Related]  

  • 44. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.
    Jin J; Simmons G
    Clin Vaccine Immunol; 2016 Jul; 23(7):535-9. PubMed ID: 27226280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basic principles and stages in testing new vaccines against respiratory viruses.
    Zykov MP; Zlydnikov DM; Shvetsova EG; Sirotenko EA; Rumovsky VI; Shaposhnikova RP
    Am Rev Respir Dis; 1976 Jan; 113(1):61-6. PubMed ID: 1247217
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunity to viruses: learning from successful human vaccines.
    Pulendran B; Oh JZ; Nakaya HI; Ravindran R; Kazmin DA
    Immunol Rev; 2013 Sep; 255(1):243-55. PubMed ID: 23947360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arenaviral vaccine vectors to combat infectious diseases.
    Dhanwani R; Ly H
    Oncotarget; 2016 Jul; 7(29):44875. PubMed ID: 27391429
    [No Abstract]   [Full Text] [Related]  

  • 49. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
    Delrue I; Verzele D; Madder A; Nauwynck HJ
    Expert Rev Vaccines; 2012 Jun; 11(6):695-719. PubMed ID: 22873127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging viruses and current strategies for vaccine intervention.
    Afrough B; Dowall S; Hewson R
    Clin Exp Immunol; 2019 May; 196(2):157-166. PubMed ID: 30993690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
    Volz A; Sutter G
    Adv Virus Res; 2017; 97():187-243. PubMed ID: 28057259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Invasive diseases: new vaccines and vaccination strategies.
    Crovari P
    J Prev Med Hyg; 2012 Jun; 53(2):49. PubMed ID: 23240159
    [No Abstract]   [Full Text] [Related]  

  • 53. Advances in fish vaccine delivery.
    Plant KP; Lapatra SE
    Dev Comp Immunol; 2011 Dec; 35(12):1256-62. PubMed ID: 21414351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.
    Logue J; Crozier I; Jahrling PB; Kuhn JH
    Expert Rev Vaccines; 2020 Jan; 19(1):85-103. PubMed ID: 31937163
    [No Abstract]   [Full Text] [Related]  

  • 55. Some unmet challenges in the immunology of viral infections.
    Rouse BT; Lukacher AE
    Discov Med; 2010 Oct; 10(53):363-70. PubMed ID: 21034678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Specific immunoprophylaxis of some viral diseases in cattle.
    Rola J; Polak MP; ZmudziƄski JF
    Pol J Vet Sci; 2005; 8(4):315-21. PubMed ID: 16385857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vaccinations: the present and future prospects].
    Llorens-Terol J
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():24-31. PubMed ID: 2490621
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaccines and viral antigenic diversity.
    Mumford JA
    Rev Sci Tech; 2007 Apr; 26(1):69-90. PubMed ID: 17633294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccines for emerging and re-emerging viral diseases of companion animals.
    McVey DS; Kennedy M
    Vet Clin North Am Small Anim Pract; 2008 Jul; 38(4):903-17, ix-x. PubMed ID: 18501286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of the bursa of Fabricius in the immune response to vaccinal antigens and the development of immune tolerance in chicks (Gallus domesticus) vaccinated at a very young age.
    Ifrah ME; Perelman B; Finger A; Uni Z
    Poult Sci; 2017 Jan; 96(1):51-57. PubMed ID: 27418658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.